Lyndra Therapeutics, Inc. — Form D

Lyndra Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-28. The offering totals $60.9M, of which $55.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Zafi Giovanni AvnurDirectorWatertown, MA
Edmund P HarriganDirectorWatertown, MA
Amy W SchulmanDirectorWatertown, MA
Amy W SchulmanExecutive OfficerWatertown, MA
Amy SchulmanDirectorCambridge, MA
Robert LangerDirectorPittsburgh, PA
Catherine ReynoldsDirectorDurham, NC
Zafi S AvnurDirectorWatertown, MA
Ashish S SinghDirectorWatertown, MA
Jessica BallingerDirectorWatertown, MA
Jessica BallingerExecutive OfficerWatertown, MA
Doug S DachilleDirectorWatertown, MA
Patricia S HurterDirectorWatertown, MA
Catherine S ReynoldsDirectorWatertown, MA
Helene S MadonickDirectorWatertown, MA
Carlo Giovanni TraversoDirectorWatertown, MA
Jillian Moo-YoungDirectorWatertown, MA
Doug Giovanni DachilleDirectorWatertown, MA
Jessica Giovanni BallingerExecutive OfficerWatertown, MA
Patricia HurterDirectorWatertown, MA
Patricia HurterExecutive OfficerWatertown, MA
Zafi AvnurDirectorWatertown, MA
Catherine Giovanni ReynoldsDirectorWatertown, MA
Ashish Giovanni SinghDirectorWatertown, MA
Robert Giovanni LangerDirectorWatertown, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-12-29D$206.1M$122.7M
2023-06-07D$179.3M$20.4M
2021-06-23D$65.0M$60.5M
2017-04-19D/A$23.1M$23.1M
2017-03-07D/A$20.1M$20.1M
2017-02-10D/A$17.1M$17.1M
2016-07-13D$5.9M$5.9M

More